Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (2r)-2-((6-benzylamino-9-(propan-2-yl)-9h-purin-2-yl)amino)butan-1-ol
2. 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
3. Cyc 202
4. Cyc-202
5. Cyc202
6. R Roscovitine
7. R-roscovitine
8. Roscovitine
1. Roscovitine
2. 186692-46-6
3. R-roscovitine
4. (r)-roscovitine
5. Cyc202
6. Cyc-202
7. Cyc 202
8. Seliciclib [inn]
9. 2-(r)-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
10. Seliciclib (roscovitine)
11. Roscovitine (seliciclib,cyc202)
12. (r)-2-((6-(benzylamino)-9-isopropyl-9h-purin-2-yl)amino)butan-1-ol
13. Nsc-701554
14. Al-39256
15. Chembl14762
16. 0es1c2kq94
17. Chebi:45307
18. (2r)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol
19. Nsc701554
20. (2r)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol
21. (2r)-2-((6-benzylamino-9-(propan-2-yl)-9h-purin-2-yl)amino)butan-1-ol
22. (2r)-2-{[6-(benzylamino)-9-(propan-2-yl)-9h-purin-2-yl]amino}butan-1-ol
23. Rrc
24. Rosco
25. (2r)-2-{[6-(benzylamino)-9-(1-methylethyl)-9h-purin-2-yl]amino}butan-1-ol
26. (2r)-2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9h-purin-2-yl]amino]-1-butanol
27. Nsc 701554
28. Unii-0es1c2kq94
29. 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
30. Bmk1-e12
31. 1unl
32. 3ddq
33. (2r)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9h-purin-2-yl)amino)-1-butanol
34. 1-butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9h-purin-2-yl)amino)-, (2r)-
35. 1-butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9h-purin-2-yl]amino]-, (2r)-
36. Mfcd02266401
37. 2a4l
38. Seliciclib [mi]
39. Biomolki_000048
40. 1-butanol, (2r)-
41. Roscovitine(seliciclib)
42. Biomolki2_000054
43. M02443
44. Seliciclib [who-dd]
45. Cbiol_002016
46. Lopac0_001102
47. Schembl94728
48. Bspbio_001078
49. Kbiogr_000418
50. Kbioss_000418
51. Mls006011028
52. Bdbm7533
53. Cid_160355
54. Gtpl6035
55. Roscovitine, >=98% (tlc)
56. Bcbcmap01_000013
57. Kbio2_000418
58. Kbio2_002986
59. Kbio2_005554
60. Kbio3_000795
61. Kbio3_000796
62. Dtxsid20171928
63. Ex-a052
64. Bcpp000087
65. Bio1_000302
66. Bio1_000791
67. Bio1_001280
68. Bio2_000379
69. Bio2_000859
70. Cc205
71. Hms1362f19
72. Hms1792f19
73. Hms1990f19
74. Hms3229n13
75. Hms3403f19
76. Amy10845
77. Bcp01760
78. Roscovitine (seliciclib, Cyc202)
79. Zinc1649340
80. Hsci1_000092
81. Nsc800881
82. S1153
83. Akos005146319
84. Ac-2416
85. Ccg-100652
86. Db06195
87. Nsc-800881
88. Idi1_002134
89. Roscovitine - Cas 186692-46-6
90. Smp1_000266
91. 2,6,9-trisubstituted Purine Deriv. 28
92. Ncgc00094374-01
93. Ncgc00094374-02
94. Ncgc00094374-03
95. Ncgc00094374-04
96. Ncgc00094374-05
97. Ncgc00094374-13
98. Ncgc00094374-15
99. As-56277
100. Hy-30237
101. Nci60_036420
102. Smr004702823
103. Sw220195-1
104. K00020
105. 692r466
106. A813074
107. J-011999
108. J-524224
109. Q3494619
110. Brd-k07691486-001-03-1
111. Brd-k07691486-001-05-6
112. (2r)-2-[[6-(benzylamino)-9-propan-2-yl-purin-2-yl]amino]butan-1-ol
113. (2r)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol
114. (2r)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol
115. (r)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9h-purin-2-yl)amino)-1-butanol
116. 1-butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9h-purin-2-yl)amino)-, (r)-
117. 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]- 9h-purin-2-yl]amino]-(r)-1-butanol
| Molecular Weight | 354.4 g/mol |
|---|---|
| Molecular Formula | C19H26N6O |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 8 |
| Exact Mass | 354.21680947 g/mol |
| Monoisotopic Mass | 354.21680947 g/mol |
| Topological Polar Surface Area | 87.9 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 417 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in breast cancer, lung cancer, lymphoma (unspecified), multiple myeloma, leukemia (lymphoid), and cancer/tumors (unspecified).
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
32
PharmaCompass offers a list of Seliciclib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Seliciclib manufacturer or Seliciclib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Seliciclib manufacturer or Seliciclib supplier.
PharmaCompass also assists you with knowing the Seliciclib API Price utilized in the formulation of products. Seliciclib API Price is not always fixed or binding as the Seliciclib Price is obtained through a variety of data sources. The Seliciclib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Seliciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Seliciclib, including repackagers and relabelers. The FDA regulates Seliciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Seliciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Seliciclib supplier is an individual or a company that provides Seliciclib active pharmaceutical ingredient (API) or Seliciclib finished formulations upon request. The Seliciclib suppliers may include Seliciclib API manufacturers, exporters, distributors and traders.
Seliciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Seliciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Seliciclib GMP manufacturer or Seliciclib GMP API supplier for your needs.
A Seliciclib CoA (Certificate of Analysis) is a formal document that attests to Seliciclib's compliance with Seliciclib specifications and serves as a tool for batch-level quality control.
Seliciclib CoA mostly includes findings from lab analyses of a specific batch. For each Seliciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Seliciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Seliciclib EP), Seliciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Seliciclib USP).
